![PDF) Real-world use of once-weekly semaglutide in patients with type 2 diabetes: Results from the SURE Switzerland multicentre, prospective, observational study PDF) Real-world use of once-weekly semaglutide in patients with type 2 diabetes: Results from the SURE Switzerland multicentre, prospective, observational study](https://i1.rgstatic.net/publication/352912795_Real-world_use_of_once-weekly_semaglutide_in_patients_with_type_2_diabetes_Results_from_the_SURE_Switzerland_multicentre_prospective_observational_study/links/60df7d8b92851ca944a2f74f/largepreview.png)
PDF) Real-world use of once-weekly semaglutide in patients with type 2 diabetes: Results from the SURE Switzerland multicentre, prospective, observational study
![Kreis SÜW: Sparkassenchef Bernd Jung über die Zukunft der Sparkassenlandschaft - Neustadt - DIE RHEINPFALZ Kreis SÜW: Sparkassenchef Bernd Jung über die Zukunft der Sparkassenlandschaft - Neustadt - DIE RHEINPFALZ](https://www.rheinpfalz.de/cms_media/module_img/4987/2493865_2_articledetail_91-130904157_4h9a0434.jpg)
Kreis SÜW: Sparkassenchef Bernd Jung über die Zukunft der Sparkassenlandschaft - Neustadt - DIE RHEINPFALZ
![Real-world use of once-weekly semaglutide in patients with type 2 diabetes: Results from the SURE Switzerland multicentre, prospective, observational study - Diabetes Research and Clinical Practice Real-world use of once-weekly semaglutide in patients with type 2 diabetes: Results from the SURE Switzerland multicentre, prospective, observational study - Diabetes Research and Clinical Practice](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/da3f0894-7dc2-4c93-9a0a-e35011ece30c/gr1.jpg)